COVID-19 Research Paper Volume 13, Issue 2 pp 1591—1607

Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases

The dynamic changes over 5 consecutive days in myocardial markers in critical type COVID-19 patients with or without anticoagulation treatment. (A, B) hsTNI; (C, D) LDH; (E, F) HBDH; (G, H) CK; (I, J) CK-MB. All P values can be found in Supplementary Table 2. COVID-19: coronavirus disease 2019, NAC: non-anticoagulant; hsTNI: high-sensitivity troponin, LDH: lactic dehydrogenase, HBDH: hydroxybutyrate dehydrogenase, CK: creatine kinase, CK-MB: creatine kinase-MB.

Figure 5. The dynamic changes over 5 consecutive days in myocardial markers in critical type COVID-19 patients with or without anticoagulation treatment. (A, B) hsTNI; (C, D) LDH; (E, F) HBDH; (G, H) CK; (I, J) CK-MB. All P values can be found in Supplementary Table 2. COVID-19: coronavirus disease 2019, NAC: non-anticoagulant; hsTNI: high-sensitivity troponin, LDH: lactic dehydrogenase, HBDH: hydroxybutyrate dehydrogenase, CK: creatine kinase, CK-MB: creatine kinase-MB.